Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
IBA launches myQA Blue Phantom³ for radiation therapy quality assurance
Fastest automatic levelling offering on the marketSeamless integration with all linear acceleratorsLouvain-la-Neuve, Belgium, 2 May 2025– IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and a leading provider of dosimetry and quality assurance (QA) solutions, announces the launch of myQA Blue Phantom³ at the European Society for Radiotherapy and Oncology (ESTRO) 2025 annual congress in Vienna, Austria. This innovative solution is set to...
Nasdaq GlobeNewswire
02/05/2025
Filter Media Market Expands Amid Rising Demand in Industrial and Biomedical…
Claim Your Free Report: https://reports.valuates.com/request/sample/QYRE-Auto-4F877/Global_Filter_Media_Market Claim Your Free Report:https://reports.valuates.com/request/sample/QYRE-Auto-4F877/Global_Filter_Media_Market Major Factors Driving the Growth of Filter Media Market: The filter media market continues to grow steadily, supported by expanding applications across industries ranging from biomedical and automotive to food processing and industrial manufacturing. The rising...
PR Newswire
02/05/2025
CARBIOS files its 2024 Universal Registration Document
Clermont-Ferrand (France), May 2, 2025 (6:00 pm CEST).CARBIOS, (Euronext Growth Paris: ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, announcest o its shareholders and the financial community that its 2024 Universal Registration Document including the annual report, the management report and the report on corporate governance was filed with the French Financial Market Authority (Autorité des...
Nasdaq GlobeNewswire
02/05/2025
Sanofi: Information concerning the total number of voting rights and shares -…
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of theCode de commerce(the French Commercial Code) and article 223-16 of theRèglement général de l'Autorité des Marchés Financiers(Regulation of the French stock market authority) Sanofi a Frenchsociété anonymewith a registered share capital of €2,452,461,656 Registered office : 46, avenue de la Grande Armée - 75017 Paris - France Registered at the Paris...
Nasdaq GlobeNewswire
02/05/2025
Burn Care Market worth $3.35 billion by 2030 with 5.6% CAGR | MarketsandMarkets™
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=247121470 Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=247121470 Browse in-depth TOC on "Burn Care Market" 345 - Tables 45 - Figures 302 - Pages By Based on products,the burn care market is categorized into five segments: advanced burn dressings, burn wound therapy devices, biologics, traditional burn care products, and other burn care products...
PR Newswire
02/05/2025
The 137th Canton Fair Sees a Booming Market for All-Age Toys
"This collection reflects the evolution of toys," said Chen Xiaowei, the company's Deputy Marketing Director. "They're no longer just for children. We're seeing a growing trend among young adults who enjoy the process of building and the beauty of the finished product." According to the company, its sub-brand PANLOS is specifically designed with this audience in mind, targeting consumers between 18 and 35. "This collection reflects the evolution of toys," saidChen…
PR Newswire
02/05/2025
Seegene's CURECA(TM) Emerges as a Potential Game Changer in End-to-End PCR…
More than 2,300 attendees — including dignitaries from Italy, Spain, Germany, France, and Canada — visited Seegene's booth to view the conceptual video introducing the CURECATM. "It was evident that the Seegene booth attracted considerable attention at ESCMID," said one professional from academia. More than 2,300 attendees — including dignitaries fromItaly,Spain,Germany,France, andCanada— visited Seegene's booth to view the conceptual video introducing the CURECA TM. "It was...
PR Newswire
02/05/2025
Alvotech Announces Webcast of First Quarter 2025 Financial Results on May 8…
Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results for the first quarter ended March 31, 2025, after U.S. markets close on Wednesday, May 7, 2025. Alvotech will also conduct a conference call with analysts to present the financial results and recent business highlights on Thursday May 8, 2025, at 8:00 am EDT (12:00 noon GMT, 14:00 CET). Live...
Nasdaq GlobeNewswire
02/05/2025
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities…
ORION CORPORATIONSTOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 2 May 2025 at 15.15 EEST Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a disclosure under Chapter 9, Section 5 of the Securities Market Act, according to which the total number of Orion shares owned directly, indirectly and through financial instruments by BlackRock, Inc. and its funds decreased on 1...
Nasdaq GlobeNewswire
02/05/2025
Implantica presents the first quarter 2025 on May 9 at 15:00 CEST
If you wish to participate via webcast, please use the following link: If you wish to participate via webcast, please use the following link: If you wish to participate via teleconference, please register on the link below. After registration, you will be provided the phone number and a conference ID to access the conference. Speakers: For further information, please contact: Nicole Pehrsson, Investor Relations Telephone (CH): +41 (0)79 335 09 49nicole.pehrsson@implantica...
PR Newswire
02/05/2025
Chengdu Origen and Vanotech Announce First Patient Dosed in VAN-2401 Phase 1…
Clinical trial of KH658 evaluates single suprachoroidal space administration of gene-therapy treatment for wet AMD CHENGDU, China and ROCKAWAY, N.J., May02, 2025(GLOBE NEWSWIRE) -- Chengdu Origen Biotechnology Co., Ltd. (“Chengdu Origen”) and Vanotech Ltd. (“Vanotech”) announced today the first patient dosed in the VAN-2401 multi-center Phase 1 clinical trial evaluating treatment with KH658 for patients with wet Age-related Macular Degeneration (wet AMD). This multi-center, open-label,...
Nasdaq GlobeNewswire
02/05/2025
Orion Corporation: Managers' transactions – Karen Lykke Sørensen
ORION CORPORATIONMANAGERS' TRANSACTIONS2 MAY 2025 at 11.45 EEST Orion Corporation: Managers' transactions – Karen Lykke Sørensen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.Orion Oyj - Managers' Transactions ____________________________________________ Person subject to the...
Nasdaq GlobeNewswire
02/05/2025
Orion Corporation: Managers' transactions – Henrik Stenqvist
ORION CORPORATIONMANAGERS' TRANSACTIONS2 MAY 2025 at 11.45 EEST Orion Corporation: Managers' transactions – Henrik Stenqvist Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.Orion Oyj - Managers' Transactions ____________________________________________ Person subject to the notification...
Nasdaq GlobeNewswire
02/05/2025
Orion Corporation: Managers' transactions – Ari Lehtoranta
ORION CORPORATIONMANAGERS' TRANSACTIONS2 MAY 2025 at 11.45 EEST Orion Corporation: Managers' transactions – Ari Lehtoranta Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.Orion Oyj - Managers' Transactions ____________________________________________ Person subject to the notification...
Nasdaq GlobeNewswire
02/05/2025
Orion Corporation: Managers' transactions – Veli-Matti Mattila
ORION CORPORATIONMANAGERS' TRANSACTIONS2 MAY 2025 at 11.45 EEST Orion Corporation: Managers' transactions – Veli-Matti Mattila Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.Orion Oyj - Managers' Transactions ____________________________________________ Person subject to the notification...
Nasdaq GlobeNewswire
02/05/2025
Orion Corporation: Managers' transactions – Hilpi Rautelin
ORION CORPORATIONMANAGERS' TRANSACTIONS2 MAY 2025 at 11.45 EEST Orion Corporation: Managers' transactions – Hilpi Rautelin Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.Orion Oyj - Managers' Transactions ____________________________________________ Person subject to the notification...
Nasdaq GlobeNewswire
02/05/2025
Orion Corporation: Managers' transactions – Eija Ronkainen
ORION CORPORATIONMANAGERS' TRANSACTIONS2 MAY 2025 at 11.45 EEST Orion Corporation: Managers' transactions – Eija Ronkainen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.Orion Oyj - Managers' Transactions ____________________________________________ Person subject to the notification...
Nasdaq GlobeNewswire
02/05/2025
Orion Corporation: Managers' transactions – Maziar Mike Doustdar
ORION CORPORATIONMANAGERS' TRANSACTIONS2 MAY 2025 at 11.45 EEST Orion Corporation: Managers' transactions – Maziar Mike Doustdar Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.Orion Oyj - Managers' Transactions ____________________________________________ Person subject to the...
Nasdaq GlobeNewswire
02/05/2025
Orion Corporation: Managers' transactions – Kari Jussi Aho
ORION CORPORATIONMANAGERS' TRANSACTIONS2 MAY 2025 at 11.45 EEST Orion Corporation: Managers' transactions – Kari Jussi Aho Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.Orion Oyj - Managers' Transactions ____________________________________________ Person subject to the notification...
Nasdaq GlobeNewswire
02/05/2025
Aktiia secures $42 million in Series B funding round and rebrands to Hilo
The latest investment builds on a period of significant momentum for the company during which it has achieved several major milestones, including securing CE marking for its innovative mobile phone camera blood pressure monitoring technology, securing regulatory approvals in Canada, Australia and Saudi Arabia, achieving 76% compounded annual revenue growth, and completing a pivotal clinical trial ahead of its U.S. FDA application submission. This Series B funding will fuel continued product…
PR Newswire
02/05/2025
EnteroBiotix to Present Results from Phase 1b trial in Liver Cirrhosis at EASL…
Glasgow, Scotland – 2 May 2025.EnteroBiotix Limited ('EnteroBiotix'), a clinical-stage biopharmaceutical company focussed on developing best-in-class drugs for gut health, today announced that results from its IMPuLCE Phase 1b trial evaluating EBX-102, the Company's next-generation full-spectrum microbiome product, in patients with liver cirrhosis will be shared as an oral presentation at the European Association for the Study of the Liver (EASL) Congress 2025, taking place in Amsterdam,...
Nasdaq GlobeNewswire
02/05/2025
Bavarian Nordic Receives Marketing Authorization for Chikungunya Vaccine for…
COPENHAGEN, Denmark, May 2, 2025– Bavarian Nordic A/S (OMX: BAVA) announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization in the United Kingdom (UK) for VIMKUNYA ®(recombinant, adsorbed) for active immunization for the prevention of disease caused by chikungunya virus in individuals 12 years and older.The vaccine was approved following MHRA review under the international recognition procedure, which is a targeted...
Nasdaq GlobeNewswire
02/05/2025
301,521 Orion Corporation A shares converted into B shares
ORION CORPORATIONSTOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 2 MAY 2025 at 9.00 EEST 301,521 Orion Corporation A shares converted into B shares In accordance with Section 3 of the Articles of Association of Orion Corporation, 301,521 A shares have been converted into 301,521 B shares. The conversion has been entered into the Trade Register on 2 May 2025.The total number of shares in Orion Corporation is 141,134,278...
Nasdaq GlobeNewswire
02/05/2025
Idorsia issues invitation to the 2025 Annual General Meeting of Shareholders
Allschwil, Switzerland – May 2, 2025Idorsia Ltd (SIX: IDIA) today issued the invitation to the upcoming Annual General Meeting (AGM) of Shareholders on behalf of the Board of Directors. The meeting to approve the Annual Report of the year ending December 31, 2024, will be held on Wednesday, May 28, 2025, at 09.00 CEST at the Congress Center, Messe Basel, Switzerland. Jean-Paul Clozel, Chairman of the Board of Idorsia, commented:“The team at Idorsia continues to go the extra mile to...
Nasdaq GlobeNewswire
02/05/2025
Altri Comunicati
